自动化神经心理评估指标作为系统性红斑狼疮认知障碍筛查工具的有效性证据
本研究以211例连续成人SLE患者为对象,评估自动化神经心理评估指标(ANAM)以ACR神经心理成套测验(NB)为金标准筛查认知障碍的有效性。结果显示最佳ANAM模型区分认知障碍的AUC达81%和84%,衍生复合指数及界值的敏感性为78-80%、特异性为70%。
要点
- ANAM最佳模型区分SLE认知障碍的AUC为81%和84%。
- 衍生复合指数界值敏感性78-80%、特异性70%。
- 无认知障碍患者在多数ANAM分测验表现更优。
核心结论
- 本研究支持ANAM对成人SLE认知障碍具有区分有效性,并可用于认知筛查。
- 衍生的复合指数与界值增强了临床适用性。
研究设计与样本
- 连续纳入211例成人SLE患者(女性与男性),均接受ANAM与ACR NB评估。
- 以ACR NB作为认知障碍分类的金标准。
- 通过logistic回归分析选择最具区分度的分测验,计算AUC评估ANAM有效性。
主要发现
- 无认知障碍患者在多数ANAM分测验上表现更好,支持ANAM的区分有效性。
- 选定的ANAM分测验在最佳模型中可准确识别认知障碍,AUC分别为81%和84%。
关键数值与推荐
- 最佳ANAM模型的AUC为81%和84%。
- 衍生复合指数及界值的敏感性为78-80%,特异性为70%。
临床怎么用
- ANAM可作为成人SLE认知障碍的筛查工具,衍生复合指数与界值有助于临床推广应用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Screening for cognitive impairment in systemic lupus erythematosus (SLE) conventionally relies on the American College of Rheumatology (ACR) neuropsychologic battery (NB), which is not universally available. To develop a more accessible screening approach, we assessed validity of the Automated Neuropsychological Assessment Metrics (ANAM). Using the ACR NB as the gold standard for cognitive impairment classification, the objectives were 1) to measure overall discriminative validity of the ANAM for cognitive impairment versus no cognitive impairment, 2) to identify ANAM subtests and scores that best differentiate patients with cognitive impairment from those with no cognitive impairment, and 3) to derive ANAM composite indices and cutoffs. METHODS: A total of 211 consecutive adult patients, female and male, with SLE were administered the ANAM and ACR NB. 1) For overall discriminative validity of the ANAM, we compared patients with cognitive impairment versus those with no cognitive impairment on 4 scores. 2) Six ANAM models using different scores were developed, and the most discriminatory subtests were selected using logistic regression analyses. The area under the receiver operating characteristic curve (AUC) was calculated to establish ANAM validity against the ACR NB. 3) ANAM composite indices and cutoffs were derived for the best models, and sensitivities and specificities were calculated. RESULTS: Patients with no cognitive impairment performed better on most ANAM subtests, supporting ANAM's discriminative validity. Cognitive impairment could be accurately identified by selected ANAM subtests with top models, demonstrating excellent AUCs of 81% and 84%. Derived composite indices and cutoffs demonstrated sensitivity of 78-80% and specificity of 70%. CONCLUSION: This study provides support for ANAM's discriminative validity for cognitive impairment and utility for cognitive screening in adult SLE. Derived composite indices and cutoffs enhance clinical applicability.
引用
- Tayer-Shifman OE, Green R, Beaton DE, et al. Validity Evidence for the Use of Automated Neuropsychologic Assessment Metrics As a Screening Tool for Cognitive Impairment in Systemic Lupus Erythematosus. Arthritis Care Res (Hoboken). 2020. PMID: 31628718. doi:10.1002/acr.24096
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。